Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06589336 · ClinicalTrials.gov registry record · NA
SUSTAIN: Behavior Change and Nutrition Security for CKMS
A NA study of Cardiovascular Disease Other and Stage 2 Cardiovascular-Kidney-Metabolic Syndrome, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT06589336: Completed NA study of Cardiovascular Disease Other and Stage 2 Cardiovascular-Kidney-Metabolic Syndrome, sponsored by Ohio State University.
NCT06589336 is a NA study of Cardiovascular Disease Other and Stage 2 Cardiovascular-Kidney-Metabolic Syndrome that has completed, run by Ohio State University. The registered enrollment target is 106 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06589336, a NA study of Cardiovascular Disease Other and Stage 2 Cardiovascular-Kidney-Metabolic Syndrome, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the feasibility and engagement of participants in the SUSTAIN intervention compared to enhanced usual care over 24 weeks through mixed-methods measurement of participant enrollment, adherence, retention, and engagement (counseling, screenings, referrals, and uptake). Methods: Leveraging rigorous quantitative and qualitative evaluation, the study team will identify mechanisms driving intervention feasibility and engagement. Hypothesis: SUSTAIN will be feasible with a high degree of engagement among Medicaid-enrolled participants with Stage 2 CKMS in comparison to enhanced usual care.
Primary Outcome
Enrollment will be determined by the percent of eligible participants who enroll in the study.
Conditions Studied
Interventions
- OTHER Dietary changes via Instacart vouchers
- OTHER Dietary changes via access to Mid-Ohio Farmacy
- OTHER Behavior changes via access to Health Impact Ohio Hub
- OTHER Behavioral nutrition counseling
- OTHER Cooking classes
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2024-08-26 |
| Est. Completion | 2025-08-29 |
| Phase | NA |
What the finished NCT06589336 record still lists
NCT06589336 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Cardiovascular Disease Other appearing as the primary indexed condition, and to 5 interventions - of which Dietary changes via Instacart vouchers is the first listed.
NCT06589336 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06589336 about?
NCT06589336 is a clinical study titled "SUSTAIN: Behavior Change and Nutrition Security for CKMS". To determine the feasibility and engagement of participants in the SUSTAIN intervention compared to enhanced usual care over 24 weeks through mixed-methods measurement of participant enrollment, adherence, retention, and engagement (counseling, screenings, referrals, and uptake). Methods: Leveraging...
What is the current status of trial NCT06589336?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2024-08-26. Estimated completion is 2025-08-29.
What conditions does trial NCT06589336 study?
This clinical trial studies the following conditions: Cardiovascular Disease Other, Stage 2 Cardiovascular-Kidney-Metabolic Syndrome.
What interventions are being tested in trial NCT06589336?
The interventions under investigation include: Dietary changes via Instacart vouchers (OTHER), Dietary changes via access to Mid-Ohio Farmacy (OTHER), Behavior changes via access to Health Impact Ohio Hub (OTHER), Behavioral nutrition counseling (OTHER), Cooking classes (OTHER).
Who is sponsoring clinical trial NCT06589336?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06589336 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease Other
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06589336's enrollment target sits among peer trials
106 830th of 2000 higher than 1,167 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI